These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23247987)

  • 21. C5b-9-activated, K(v)1.3 channels mediate oligodendrocyte cell cycle activation and dedifferentiation.
    Tegla CA; Cudrici C; Rozycka M; Soloviova K; Ito T; Singh AK; Khan A; Azimzadeh P; Andrian-Albescu M; Khan A; Niculescu F; Rus V; Judge SI; Rus H
    Exp Mol Pathol; 2011 Aug; 91(1):335-45. PubMed ID: 21540025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention.
    Fishelson Z; Kirschfink M
    Front Immunol; 2019; 10():752. PubMed ID: 31024572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyrosine phosphorylation and activation of Janus kinase 1 and STAT3 by sublytic C5b-9 complement complex in aortic endothelial cells.
    Niculescu F; Soane L; Badea T; Shin M; Rus H
    Immunopharmacology; 1999 May; 42(1-3):187-93. PubMed ID: 10408379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination.
    Carney DF; Lang TJ; Shin ML
    J Immunol; 1990 Jul; 145(2):623-9. PubMed ID: 2164064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Terminal complement complex C5b-9-treated human monocyte-derived dendritic cells undergo maturation and induce Th1 polarization.
    Chen Y; Yang C; Jin N; Xie Z; Tang Y; Fei L; Jia Z; Wu Y
    Eur J Immunol; 2007 Jan; 37(1):167-76. PubMed ID: 17171756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement (C5b-9) induces glomerular epithelial cell DNA synthesis but not proliferation in vitro.
    Shankland SJ; Pippin JW; Couser WG
    Kidney Int; 1999 Aug; 56(2):538-48. PubMed ID: 10432393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
    Gancz D; Donin N; Fishelson Z
    Mol Immunol; 2009 Dec; 47(2-3):310-7. PubMed ID: 19864026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes.
    Pippin JW; Durvasula R; Petermann A; Hiromura K; Couser WG; Shankland SJ
    J Clin Invest; 2003 Mar; 111(6):877-85. PubMed ID: 12639994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone Deacetylase SIRT1 Mediates C5b-9-Induced Cell Cycle in Oligodendrocytes.
    Tatomir A; Rao G; Boodhoo D; Vlaicu SI; Beltrand A; Anselmo F; Rus V; Rus H
    Front Immunol; 2020; 11():619. PubMed ID: 32328069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement activation and atherosclerosis.
    Niculescu F; Rus H
    Mol Immunol; 1999; 36(13-14):949-55. PubMed ID: 10698349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane signaling by complement C5b-9, the membrane attack complex.
    Nicholson-Weller A; Halperin JA
    Immunol Res; 1993; 12(3):244-57. PubMed ID: 8288945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of signal transduction activated by sublytic assembly of terminal complement complexes on nucleated cells.
    Niculescu F; Rus H
    Immunol Res; 2001; 24(2):191-9. PubMed ID: 11594456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C5b-9 terminal complex protects oligodendrocytes from apoptotic cell death by inhibiting caspase-8 processing and up-regulating FLIP.
    Cudrici C; Niculescu F; Jensen T; Zafranskaia E; Fosbrink M; Rus V; Shin ML; Rus H
    J Immunol; 2006 Mar; 176(5):3173-80. PubMed ID: 16493077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of apoptosis signal-regulating kinase 1 in complement-mediated glomerular epithelial cell injury.
    Ren G; Huynh C; Bijian K; Cybulsky AV
    Mol Immunol; 2008 Apr; 45(8):2236-46. PubMed ID: 18178252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activating transcription factor 3 (ATF3) promotes sublytic C5b-9-induced glomerular mesangial cells apoptosis through up-regulation of Gadd45α and KLF6 gene expression.
    Xu K; Zhou Y; Qiu W; Liu X; Xia M; Liu L; Liu X; Zhao D; Wang Y
    Immunobiology; 2011 Aug; 216(8):871-81. PubMed ID: 21396734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sublytic C5b-9 triggers glomerular mesangial cell apoptosis in rat Thy-1 nephritis via Gadd45 activation mediated by Egr-1 and p300-dependent ATF3 acetylation.
    He F; Zhou M; Yu T; Zhao D; Zhang J; Qiu W; Lu Y; Liu Y; Wang L; Wang Y
    J Mol Cell Biol; 2016 Dec; 8(6):477-491. PubMed ID: 27190312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sublytic terminal complement attack induces c-fos transcriptional activation in myotubes.
    Badea TD; Park JH; Soane L; Niculescu T; Niculescu F; Rus H; Shin ML
    J Neuroimmunol; 2003 Sep; 142(1-2):58-66. PubMed ID: 14512164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pumilio directs deadenylation-associated translational repression of the cyclin-dependent kinase 1 activator RGC-32.
    Brocard M; Khasnis S; Wood CD; Shannon-Lowe C; West MJ
    Nucleic Acids Res; 2018 Apr; 46(7):3707-3725. PubMed ID: 29385536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogenic gene RGC-32 is a direct target of miR-26b and facilitates tongue squamous cell carcinoma aggressiveness through EMT and PI3K/AKT signalling.
    Yang ZH; Li J; Chen WZ; Kong FS
    Cell Biochem Funct; 2020 Oct; 38(7):943-954. PubMed ID: 32325539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.
    Viedt C; Shen W; Fei J; Kamimura M; Hänsch GM; Katus HA; Kreuzer J
    Basic Res Cardiol; 2003 Nov; 98(6):353-61. PubMed ID: 14556080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.